Lexaria to Begin New Human Clinical Study in GLP-1
Go back to Lexaria to Begin New Human Clinical Study in GLP-1| (NASDAQ: LEXX) | Delayed: 2.82 +0.02 (0.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.80 | 52 Week High | $ | |||
| Open | $2.81 | 52 Week Low | $ | |||
| Day High | $2.92 | P/E | N/A | |||
| Day Low | $2.43 | EPS | $ | |||
| Volume | 103,879 | |||||



